VF
IDXX icon

VitalStone Financial’s Idexx Laboratories IDXX Stock Holding History

VitalStone Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$3K – 539
2024
Q1 		$3K Buy
+5
New +$2.73K ﹤0.01% 366
2023
Q4 		– Sell
-6
Closed -$3K – 526
2023
Q3 		$3K Buy
6
+2
+50% +$997 ﹤0.01% 333
2023
Q2 		$2K Hold
4
– – ﹤0.01% 791
2023
Q1 		$3K Hold
4
– – ﹤0.01% 271
2022
Q4 		$2K Buy
+4
New +$1.55K ﹤0.01% 444

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VitalStone Financial's IDXX Position: Q2 2024 in Review

VitalStone Financial sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 5 shares — an estimated $3K sold.

VitalStone Financial first reported a position in IDXX in Q4 2022 and held it in 5 quarters. The position peaked at $3K in Q1 2024. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • VitalStone Financial reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • VitalStone Financial sold 5 Idexx Laboratories shares in Q2 2024, an estimated $3K.
  • VitalStone Financial first reported a position in Idexx Laboratories in Q4 2022 and held it in 5 quarters.
  • VitalStone Financial's Idexx Laboratories position peaked at $3K in Q1 2024.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on VitalStone Financial's 13F filing for Q2 2024, filed 7 Aug 2024.